Huabin Ma
Impact in
- Nephrology top 5%
- Acute Kidney Injury Research
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation
Papers in
-
- Inflammasome and immune disorders 6
- Cell death mechanisms and regulation 5
-
- Ferroptosis and cancer prognosis 5
- Co-authors
- Yanfang Xu (11 shared papers)Jianfeng Wu (3 shared papers)Jing Shao (2 shared papers)Zhirong Zhang (3 shared papers)Jiahuai Han (4 shared papers)Junming Ren (2 shared papers)Suhuan Liu (1 shared paper)Linying Zhou (1 shared paper)
In The Last Decade
Huabin Ma
26 papers receiving 844 citations
Peers
Comparison fields: 5 of 77
- Nephrology 187
- Pathology and Forensic Medicine 146
- Cancer Research 121
- Molecular Biology 502
- Immunology 140
Countries citing papers authored by Huabin Ma
This map shows the geographic impact of Huabin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huabin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huabin Ma more than expected).
Fields of papers citing papers by Huabin Ma
This network shows the impact of papers produced by Huabin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huabin Ma. The network helps show where Huabin Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Huabin Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 303 | |
| 2 | 2021 | 139 | |
| 3 | 2016 | 63 | |
| 4 | 2017 | 58 | |
| 5 | 2021 | 42 | |
| 6 | 2024 | 27 | |
| 7 | 2014 | 24 | |
| 8 | 2021 | 23 | |
| 9 | 2023 | 18 | |
| 10 | 2024 | 15 | |
| 11 | 2024 | 15 | |
| 12 | 2022 | 15 | |
| 13 | 2021 | 13 | |
| 14 | 2022 | 12 | |
| 15 | 2021 | 12 | |
| 16 | 2023 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2024 | 10 | |
| 19 | 2024 | 10 | |
| 20 | 2024 | 8 |
About Huabin Ma
Huabin Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Nephrology, Pharmacology and Immunology, having authored 26 papers that have together received 849 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (6 papers), Ferroptosis and cancer prognosis (5 papers), Cell death mechanisms and regulation (5 papers), Microbial Natural Products and Biosynthesis (4 papers), Liver Disease and Transplantation (3 papers), Acute Kidney Injury Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Nephrology (187 citations), Pathology and Forensic Medicine (146 citations), Cancer Research (121 citations), Molecular Biology (502 citations) and Immunology (140 citations). Huabin Ma has collaborated with scholars based in China, Canada and Hong Kong. Frequent co-authors include Yanfang Xu, Jianfeng Wu, Jing Shao, Zhirong Zhang, Jiahuai Han, Junming Ren, Suhuan Liu, Linying Zhou, Zhe Huang and Yuze Wang. Their work appears in journals such as Cell Death and Differentiation, Journal of Natural Products, Journal of the American Society of Nephrology, Nephrology Dialysis Transplantation and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.